Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 8, 2005, Pages 4912-4919

  Schou, Jakob Hagen ^a   Pilgaard, Kasper ^a   Vilsbøll, Tina ^b   Jensen, Christine B ^a   Deacon, Carolyn F ^c   Holst, Jens Juul ^c   Vølund, Aage ^d   Madsbad, Sten ^e   Vaag, Allan A ^a  

^a STENO DIABETES CENTER   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d NOVO NORDISK A S   (Denmark)

^e HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; POLYPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BODY MASS; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LOW BIRTH WEIGHT; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TEST MEAL;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; EATING; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERGLYCEMIA; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INSULIN; ISLETS OF LANGERHANS; MALE; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS;

EID: 23844546508     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-0382     Document Type: Article

References (42)

1. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, Winter PD 1991 Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303:1019-1022
2. Hales CN, Barker DJ 2001 The thrifty phenotype hypothesis. Br Med Bull 60:5-20
3. Veening MA, Van Weissenbruch MM, Delemarre-Van De Waal HA 2002 Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age. J Clin Endocrinol Metab 87:4657-4661
4. Jaquet D, Gaboriau A, Czernichow P, Levy-Marchal C 2000 Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. J Clin Endocrinol Metab 85:1401-1406
5. Whincup PH, Cook DG, Adshead F, Taylor SJ, Walker M, Papacosta O, Alberti KG 1997 Childhood size is more strongly related than size at birth to glucose and insulin levels in 10-11-year-old children. Diabetologia 40:319-326
6. Ozanne SE, Hales CN 1999 The long-term consequences of intra-uterine protein malnutrition for glucose metabolism. Proc Nutr Soc 58:615-619
7. Phillips DI, Hirst S, Clark PM, Hales CN, Osmond C 1994 Fetal growth and insulin secretion in adult life. Diabetologia 37:592-596
8. Ravelli AC, van der Meulen JH, Michels RP, Osmond C, Barker DJ, Hales CN, Bleker OP 1998 Glucose tolerance in adults after prenatal exposure to famine. Lancet 351:173-177
9. Bavdekar A, Yajnik CS, Fall CH, Babat S, Pandit AN, Deshpande V, Bhave S, Kellingray SD, Joglekar C 1999 Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both? Diabetes 48:2422-2429
10. Yajnik CS, Fall CH, Vaidya U, Pandit AN, Bavdekar A, Bhat DS, Osmond C, Hales CN, Barker DJ 1995 Fetal growth and glucose and insulin metabolism in four-year-old Indian children. Diabet Med 12:330-336
11. Nauck M, Stockmann F, Ebert R, CreutzfeldtW1986 Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29:46-52
12. Vilsboll T, Krarup T, Deacon CF, Madsbad S, Holst JJ 2001 Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50:609-613
13. Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK, Holst JJ 2001 Determinants of the impaired secretion of glucagonlike peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 86:3717-3723
14. Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ 1996 Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2:1254-1258
15. Miyawaki K, Yamada Y, Yano H, Niwa H, Ban N, Ihara Y, Kubota A, Fujimoto S, Kajikawa M, Kuroe A, Tsuda K, Hashimoto H, Yamashita T, Jomori T, Tashiro F, Miyazaki J, Seino Y 1999 Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci USA 96:14843-14847
16. Hvidberg A, Nielsen MT, Hilsted J, Orskov C, Holst JJ 1994 Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man. Metabolism 43:104-108
17. Flint A, Raben A, Astrup A, Holst JJ 1998 Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101:515-520
18. Buteau J, Foisy S, Rhodes CJ, Carpenter L, Biden TJ, PrentkiM 2001 Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic β-cell proliferation. Diabetes 50:2237-2243
19. Buteau J, Foisy S, Joly E, Prentki M 2003 Glucagon-like peptide 1 induces pancreatic β-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 52:124-132
20. Zhou J, Wang X, Pineyro MA, Egan JM 1999 Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes 48:2358-2366
21. Zhou J, Pineyro MA, Wang X, Doyle ME, Egan JM 2002 Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX-1 and HNF3 transcription factors. J Cell Physiol 192:304-314
22. Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U, Perfetti R 2002 Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 143:4397-4408
23. Morgan LM 1998 The role of gastrointestinal hormones in carbohydrate and lipid metabolism and homeostasis: effects of gastric inhibitory polypeptide and glucagon-like peptide-1. Biochem Soc Trans 26:216-222
24. Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, Ebert R, Creutzfeldt W 1986 Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab 63:492-498
25. Jensen CB, Storgaard H, Dela F, Holst JJ, Madsbad S, Vaag AA 2002 Early differential defects of insulin secretion and action in 19-year-old Caucasian men who had low birth weight. Diabetes 51:1271-1280
26. Krarup T, Madsbad S, Moody AJ, Regeur L, Faber OK, Holst JJ, Sestoft C 1983 Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics. J Clin Endocrinol Metab 56:1306-1312
27. Krarup T, Holst JJ 1984 The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera. Regul Pept 9:35-46
28. Orskov C, Rabenhoj L, Wettergren A, Kofod H, Holst JJ 1994 Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43:535-539
29. Hovorka R, Koukkou E, Southerden D, Powrie JK, Young MA 1998 Measuring pre-hepatic insulin secretion using a population model of C-peptide kinetics: accuracy and required sampling schedule. Diabetologia 41:548-554
30. Kjems LL, Volund A, Madsbad S 2001 Quantification of β-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods. Diabetologia 44:1339-1348
31. Wallace TM, Levy JC, Matthews DR 2004 Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495
32. Mitrakou A, Vuorinen-Markkola H, Raptis G, Toft I, Mokan M, Strumph P, Pimenta W, Veneman T, Jenssen T 1992 Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemia clamp. J Clin Endocrinol Metab 75:379-382
33. Sandhu H, Wiesenthal SR, MacDonald PE, McCall RH, Tchipashvili V, Rashid S, Satkunarajah M, Irwin DM, Shi ZQ, Brubaker PL, Wheeler MB, Vranic M, Efendic S, Gracca A 1999 Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes 48:1045-1053
34. Vilsboll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ 2003 The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype. J Clin Endocrinol Metab 88:4897-4903
35. Nyholm B, Walker M, Gravholt CH, Shearing PA, Sturis J, Alberti KG, Holst JJ, Schmitz O 1999 Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of type II (non-insulin-dependent) diabetic parents: evidence of several aberrations. Diabetologia 42:1314-1323
36. Vaag AA, Holst JJ, Volund A, Beck-Nielsen HB 1996 Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM) - evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins. Eur J Endocrinol 135:425-432
37. Deacon CF, Johnsen AH, Holst JJ 1995 Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab 80:952-957
38. Qualmann C, Nauck MA, Holst JJ, Orskov C, CreutzfeldtW1995 Glucagonlike peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using α-glucosidase inhibition (acarbose). Scand J Gastroenterol 30:892-896
39. Meneilly GS, Veldhuis JD, Elahi D 1999 Disruption of the pulsatile and entropic modes of insulin release during an unvarying glucose stimulus in elderly individuals. J Clin Endocrinol Metab 84:1938-1943
40. Halban PA 1982 Differential rates of release of newly synthesized and of stored insulin from pancreatic islets. Endocrinology 110:1183-1188
41. Draznin B, Steinberg JP, Goodman M, Leitner JW, Sussman KE 1985 Control of secretion vesicle margination and lysis by glucose, IBMX, and glyburide. Am J Physiol 248:E375-E380
42. Hermann TS, Rask-Madsen C, Ihlemann N, Dominguez H, Jensen CB, Storgaard H, Vaag AA, Kober L, Torp-Pedersen C 2003 Normal insulinstimulated endothelial function and impaired insulin-stimulated muscle glucose uptake in young adults with low birth weight. J Clin Endocrinol Metab 88:1252-1257